The estimated number and proportion of community members treated for trachoma and trichiasis: Measures 3.8.1 and 3.8.2
On this page:
The estimated number, and proportion of:
- cases, household and community contacts who were treated in communities where active trachoma was identified
- First Nations adults with trichiasis who were treated.
The screening and treatment frequency for trachoma in at-risk communities is based on the trachoma prevalence rate (Figure 46 and Figure 47). Treatment for trichiasis is important for preventing vision loss.
Latest data
In 2024, in communities where active trachoma was identified, a total of 1,674 cases and household and community contacts received treatment, or 54% of people requiring treatment. This included 149 people aged 0–4 years (42% of those requiring treatment), 284 aged 5–9 years (74% of those requiring treatment), 186 aged 10–14 years (51% of those requiring treatment) and 1,055 aged 15 years and over (51% of those requiring treatment) (Figure 47).
Surgery to correct trichiasis was undertaken for 6 people aged 15 years and over in 2024. Four of the 6 surgeries took place in Western Australia.
Figure 47: Community members treated in communities where active trachoma was identified, by age, 2024
Dual vertical bar charts showing in communities where active trachoma was identified, a total of 1,674 (54%) cases and household and community contacts received treatment.
Notes
- ‘Per cent’ relates to percentage of active cases and household/ community contacts treated in communities where active trachoma was identified.
- Includes data from the 18 communities who received treatment for trachoma.
- Data are crude rates.
Source: Australian Trachoma Surveillance Report 2024 (Kirby Institute, UNSW Sydney, 2025).
By jurisdiction
In 2024, in communities where active trachoma was identified, the proportion of cases and household and community contacts who received required treatment was 87% in Western Australia (92 people treated) and 53% in the Northern Territory (1,582 people treated). No active trachoma cases were identified in South Australia. In Queensland, screening for trachoma was not undertaken in 2024 (Figure 48 – jurisdiction).
Figure 48: Trachoma treatment coverage, communities where active trachoma was identified, by jurisdiction, 2024
Dual vertical bar charts showing in communities where active trachoma was identified 87% received treatment in WA and 53% in the NT.
Notes
- Estimated as a proportion of those requiring treatment according to national guidelines.
- Includes data from the 18 communities that required treatment for trachoma.
- Data are crude rates.
- n.s. = No screening
Source: Australian Trachoma Surveillance Report 2024 (Kirby Institute, UNSW Sydney, 2025).